FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114025056> ?p ?o ?g. }

• W2114025056 endingPage "1365" @default.
• W2114025056 startingPage "1353" @default.
• W2114025056 abstract "CD44 is a molecular marker associated with cancer stem cell populations and treatment resistance in glioma. More effective therapies will result from approaches aimed at targeting glioma cells high in CD44.Glioma-initiating cell lines were derived from fresh surgical glioblastoma samples. Expression of tissue transglutaminase 2 (TGM2) was attenuated through lentivirus-mediated short hairpin RNA knockdown. MTT assay [(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] was used to evaluate the growth inhibition induced by TGM2 inhibitor. Terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling was used to evaluate cell apoptosis following TGM2 inhibition. CD44(+) glioma stem cells were sorted by flow cytometry. A nude mice orthotopic xenograft model was used to evaluate the in vivo effect of TGM2 inhibitor.TGM2 was highly expressed in CD44-high glioblastoma tissues and tumor-derived glioma-initiating cell lines. TGM2 knockdown impaired cell proliferation and induced apoptosis in CD44-high glioma-initiating cell lines. Further studies indicated that expression of inhibitor of DNA binding 1 protein (ID1) is regulated by TGM2 and might be an important mediator for TGM2-regulated cell proliferation in CD44-high glioma-initiating cell lines. TGM2 inhibitor reduces ID1 expression, suppresses cell proliferation, and induces apoptosis in CD44-high glioma-initiating cell lines. Furthermore, TGM2 is highly expressed in CD44(+) glioma stem cells, while pharmacological inhibition of TGM2 activity preferentially eliminates CD44(+) glioma stem cells. Consistently, TGM2 inhibitor treatment reduced ID1 expression and induced apoptosis in our orthotopic mice xenograft model, which can be translated into prolonged median survival in tumor-bearing mice.TGM2 regulates ID1 expression in glioma-initiating cell lines high in CD44. Targeting TGM2 could be an effective strategy to treat gliomas with high CD44 expression." @default.
• W2114025056 created "2016-06-24" @default.
• W2114025056 creator A5002368094 @default.
• W2114025056 creator A5007296593 @default.
• W2114025056 creator A5018162888 @default.
• W2114025056 creator A5020869854 @default.
• W2114025056 creator A5048686073 @default.
• W2114025056 creator A5048997744 @default.
• W2114025056 creator A5069813497 @default.
• W2114025056 creator A5074501861 @default.
• W2114025056 date "2013-07-21" @default.
• W2114025056 modified "2023-10-17" @default.
• W2114025056 title "TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells" @default.
• W2114025056 cites W1868232096 @default.
• W2114025056 cites W1964692745 @default.
• W2114025056 cites W1967638581 @default.
• W2114025056 cites W1974823430 @default.
• W2114025056 cites W1983977590 @default.
• W2114025056 cites W1988510098 @default.
• W2114025056 cites W1993356718 @default.
• W2114025056 cites W1996834104 @default.
• W2114025056 cites W1996889334 @default.
• W2114025056 cites W2004471993 @default.
• W2114025056 cites W2004755204 @default.
• W2114025056 cites W2005010556 @default.
• W2114025056 cites W2007796044 @default.
• W2114025056 cites W2018671779 @default.
• W2114025056 cites W2025183726 @default.
• W2114025056 cites W2026398932 @default.
• W2114025056 cites W2027303624 @default.
• W2114025056 cites W2031770999 @default.
• W2114025056 cites W2036806537 @default.
• W2114025056 cites W2050300062 @default.
• W2114025056 cites W2053155552 @default.
• W2114025056 cites W2060707760 @default.
• W2114025056 cites W2062701841 @default.
• W2114025056 cites W2063714301 @default.
• W2114025056 cites W2064263380 @default.
• W2114025056 cites W2084284297 @default.
• W2114025056 cites W2085362515 @default.
• W2114025056 cites W2085577027 @default.
• W2114025056 cites W2090751533 @default.
• W2114025056 cites W2107269111 @default.
• W2114025056 cites W2111727737 @default.
• W2114025056 cites W2113942802 @default.
• W2114025056 cites W2125164793 @default.
• W2114025056 cites W2126351542 @default.
• W2114025056 cites W2134066544 @default.
• W2114025056 cites W2135841078 @default.
• W2114025056 cites W2146601467 @default.
• W2114025056 cites W2149994426 @default.
• W2114025056 cites W2153899562 @default.
• W2114025056 cites W2161289668 @default.
• W2114025056 cites W2163505622 @default.
• W2114025056 doi "https://doi.org/10.1093/neuonc/not079" @default.
• W2114025056 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3779037" @default.
• W2114025056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23877317" @default.
• W2114025056 hasPublicationYear "2013" @default.
• W2114025056 type Work @default.
• W2114025056 sameAs 2114025056 @default.
• W2114025056 citedByCount "49" @default.
• W2114025056 countsByYear W21140250562014 @default.
• W2114025056 countsByYear W21140250562015 @default.
• W2114025056 countsByYear W21140250562016 @default.
• W2114025056 countsByYear W21140250562017 @default.
• W2114025056 countsByYear W21140250562018 @default.
• W2114025056 countsByYear W21140250562019 @default.
• W2114025056 countsByYear W21140250562020 @default.
• W2114025056 countsByYear W21140250562021 @default.
• W2114025056 countsByYear W21140250562022 @default.
• W2114025056 countsByYear W21140250562023 @default.
• W2114025056 crossrefType "journal-article" @default.
• W2114025056 hasAuthorship W2114025056A5002368094 @default.
• W2114025056 hasAuthorship W2114025056A5007296593 @default.
• W2114025056 hasAuthorship W2114025056A5018162888 @default.
• W2114025056 hasAuthorship W2114025056A5020869854 @default.
• W2114025056 hasAuthorship W2114025056A5048686073 @default.
• W2114025056 hasAuthorship W2114025056A5048997744 @default.
• W2114025056 hasAuthorship W2114025056A5069813497 @default.
• W2114025056 hasAuthorship W2114025056A5074501861 @default.
• W2114025056 hasBestOaLocation W21140250561 @default.
• W2114025056 hasConcept C1491633281 @default.
• W2114025056 hasConcept C153911025 @default.
• W2114025056 hasConcept C173396325 @default.
• W2114025056 hasConcept C190283241 @default.
• W2114025056 hasConcept C2778227246 @default.
• W2114025056 hasConcept C2780932548 @default.
• W2114025056 hasConcept C28328180 @default.
• W2114025056 hasConcept C502942594 @default.
• W2114025056 hasConcept C54355233 @default.
• W2114025056 hasConcept C55427017 @default.
• W2114025056 hasConcept C55493867 @default.
• W2114025056 hasConcept C62112901 @default.
• W2114025056 hasConcept C81885089 @default.
• W2114025056 hasConcept C86803240 @default.
• W2114025056 hasConcept C95444343 @default.
• W2114025056 hasConceptScore W2114025056C1491633281 @default.
• W2114025056 hasConceptScore W2114025056C153911025 @default.

• next